Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization.

We analyzed 27 samples of primary medulloblastoma, using comparative genomic hybridization and a novel statistical approach to evaluate chromosomal regions for significant gain or loss of genomic DNA. An array of nonrandom changes was found in most samples. Two discrete regions of high-level DNA amplification of chromosome bands 5p15.3 and 11q22.3 were observed in 3 of 27 tumors. Nonrandom genomic losses were most frequent in regions on chromosomes 10q (41% of samples), 11 (41%), 16q (37%), 17p (37%), and 8p (33%). Regions of DNA gain most often involved chromosomes 17q (48%) and 7 (44%). These findings suggest a greater degree of genomic imbalance in medulloblastoma than has been recognized previously and highlight chromosomal loci likely to contain oncogenes or tumor suppressor genes that may contribute to the molecular pathogenesis of this tumor.

[1]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[2]  C. James,et al.  Sporadic medulloblastomas contain PTCH mutations. , 1997, Cancer research.

[3]  P. Lichter,et al.  Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization , 1996, Genes, chromosomes & cancer.

[4]  E. Schröck,et al.  Recurrent gain of chromosome arm 7q in low‐grade astrocytic tumors studied by comparative genomic hybridization , 1996, Genes, chromosomes & cancer.

[5]  L. Rorke,et al.  Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group. , 1996, Neurosurgery.

[6]  C. Sommer,et al.  Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[7]  F. Waldman,et al.  Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. , 1996, Cancer research.

[8]  H. Scherthan,et al.  Advances in Brief Comparative Genomic in Situ Hybridization of Colon Carcinomas with Replication Error ' , 2006 .

[9]  J. Trent,et al.  Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes. , 1995, Cancer genetics and cytogenetics.

[10]  S. Wellek,et al.  Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. , 1995, Medical and pediatric oncology.

[11]  R. McLendon,et al.  Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. , 1995, Oncogene.

[12]  G. Mohapatra,et al.  Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization , 1995, Genes, chromosomes & cancer.

[13]  J. Delattre,et al.  Oncogene amplification in human gliomas: a molecular cytogenetic analysis. , 1994, Oncogene.

[14]  J Piper,et al.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.

[15]  L. Rorke,et al.  Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  O. Wiestler,et al.  Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11 p and 17p in medulloblastomas , 1994, Neuropathology and applied neurobiology.

[17]  A. Jauch,et al.  Copyright ©) American Society for Investigative Pathology Comparative Genomic Hybridization of Human Malignant Gliomas Reveals Multiple Amplification Sites and Nonrandom Chromosomal Gains and Losses , 2022 .

[18]  A. Look,et al.  Relation of tumor-cell ploidy to survival in children with medulloblastoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  D. Fults,et al.  Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme , 1993, Genes, chromosomes & cancer.

[20]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[21]  B. Johansson,et al.  Trisomy 7 in nonneoplastic cells , 1993, Genes, chromosomes & cancer.

[22]  D. Fults,et al.  Chromosome 11p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumors. , 1992, Genomics.

[23]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[24]  A. Friedman,et al.  Loss of heterozygosity for 10q loci in human gliomas , 1992, Genes, chromosomes & cancer.

[25]  J. Biegel,et al.  Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. , 1992, Cancer research.

[26]  D. Evans,et al.  The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. , 1991, British Journal of Cancer.

[27]  A T Look,et al.  Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  C. Raffel,et al.  Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors. , 1991, Cancer research.

[29]  P. Gaynon,et al.  Carboplatin in childhood brain tumors: A children's cancer study group phase II trial , 1990, Cancer.

[30]  W. Curran,et al.  Recurrent intracranial ependymomas in children survival, patterns of failure, and prognostic factors , 1990, Cancer.

[31]  V. P. Collins,et al.  Loss of genetic information in central nervous system tumors common to children and young adults , 1990, Genes, chromosomes & cancer.

[32]  Alan Agresti,et al.  Exact Inference for Contingency Tables with Ordered Categories , 1990 .

[33]  A. Look,et al.  Oncogene amplification in pediatric brain tumors. , 1990, Cancer research.

[34]  K. Weinberg,et al.  Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood. , 1990, Cancer research.

[35]  J. Biegel,et al.  Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system , 1989, Genes, chromosomes & cancer.

[36]  P. Pizzo,et al.  Principles and Practice of Pediatric Oncology , 1989 .

[37]  D. Bigner,et al.  Structural chromosomal abnormalities in human medulloblastoma. , 1988, Cancer genetics and cytogenetics.

[38]  F. Gilles,et al.  Revision of the world health organization classification of brain tumors for childhood brain tumors , 1985, Cancer.

[39]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[40]  D. Kleinbaum,et al.  Applied Regression Analysis and Other Multivariate Methods , 1978 .

[41]  E. Housepian,et al.  An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. , 1969, Radiology.

[42]  D. Stevanović.  Nevoid basal cell carcinoma syndrome. , 1967, Archives of dermatology.